HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Nobutaka Hattori Selected Research

Parkinson Disease (Parkinson's Disease)

11/2015Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease.
11/2015A Randomized Controlled Trial of Subcutaneous Apomorphine for Parkinson Disease: A Repeat Dose and Pharmacokinetic Study.
10/2015Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.
9/2015The Parkinson's Disease-Associated Protein Kinase LRRK2 Modulates Notch Signaling through the Endosomal Pathway.
9/2015The prevalence and risk factors of cerebral microbleeds in patients with Parkinson's disease.
8/2015Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease.
7/2015Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
7/2015Utility of the Japanese version of the 9-item Wearing-off Questionnaire.
4/2015Variants associated with Gaucher disease in multiple system atrophy.
3/2015CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Nobutaka Hattori Research Topics

Disease

99Parkinson Disease (Parkinson's Disease)
11/2015 - 05/2002
29Parkinsonian Disorders (Parkinsonism)
11/2014 - 08/2002
15Stroke (Strokes)
12/2015 - 04/2009
15Dementia (Dementias)
07/2015 - 05/2002
11Neurodegenerative Diseases (Neurodegenerative Disease)
07/2015 - 12/2003
8Dyskinesias (Dyskinesia)
01/2015 - 04/2007
6Restless Legs Syndrome (Restless Legs)
07/2015 - 03/2012
6Alzheimer Disease (Alzheimer's Disease)
07/2015 - 04/2004
5Huntington Disease (Huntington's Disease)
02/2015 - 04/2004
5Tremor (Tremors)
12/2014 - 08/2007
4Hypertension (High Blood Pressure)
12/2015 - 03/2014
4Tauopathies
11/2015 - 12/2008
4Brain Ischemia (Cerebral Ischemia)
06/2014 - 11/2009
4Atherosclerosis
02/2014 - 04/2004
4Cerebral Infarction
11/2013 - 11/2009
4Neoplasms (Cancer)
01/2013 - 02/2011
4Ischemia
08/2011 - 07/2008
3Infarction
02/2015 - 04/2009
3Frontotemporal Lobar Degeneration (Semantic Dementia)
01/2015 - 12/2008
3Endometriosis (Adenomyosis)
08/2014 - 10/2012
3Bipolar Disorder (Mania)
06/2014 - 08/2009
3Neuromyelitis Optica (Devic's Disease)
01/2013 - 09/2009
3Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2013 - 08/2002
2Prediabetic State (Prediabetes)
12/2015 - 09/2013
2Type 2 Diabetes Mellitus (MODY)
12/2015 - 08/2011
2Intracranial Embolism
04/2015 - 02/2015
2Gaucher Disease (Gaucher's Disease)
04/2015 - 01/2007
2Disease Progression
01/2015 - 01/2003
2Fever (Fevers)
01/2015 - 12/2010
2Ataxia (Dyssynergia)
12/2014 - 05/2013
2Atrophy
04/2014 - 03/2010
2Polyneuropathies (Polyneuropathy)
02/2014 - 09/2013
2Infection
01/2014 - 09/2009
2Insulin Resistance
01/2014 - 04/2009
2Human Influenza (Influenza)
01/2014 - 01/2008
2Meningitis
09/2013 - 01/2013
2Myocardial Infarction
04/2013 - 08/2011
2Hemorrhage
04/2013 - 11/2012
2Lymphoma (Lymphomas)
04/2013 - 01/2003
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2013 - 04/2006
2Aneurysm (Aneurysms)
01/2013 - 01/2011
2Nervous System Diseases (Neurological Disorders)
01/2013 - 01/2008
2Reperfusion Injury
08/2011 - 11/2009
2Neurologic Manifestations (Neurological Manifestations)
08/2011 - 11/2009
2Renal Insufficiency (Renal Failure)
12/2010 - 12/2009
2Hypercholesterolemia
08/2010 - 01/2009

Drug/Important Bio-Agent (IBA)

23Levodopa (L Dopa)FDA LinkGeneric
11/2015 - 06/2003
19Phosphotransferases (Kinase)IBA
09/2015 - 03/2006
17alpha-SynucleinIBA
02/2009 - 05/2002
13UbiquitinIBA
06/2014 - 03/2003
12Leucine (L-Leucine)FDA Link
09/2015 - 09/2006
8SynucleinsIBA
07/2015 - 11/2010
7AntibodiesIBA
07/2015 - 05/2002
6N 0437FDA Link
07/2015 - 01/2013
5Glucose (Dextrose)FDA LinkGeneric
12/2015 - 04/2009
5polyglutamineIBA
10/2015 - 10/2005
5Proteins (Proteins, Gene)IBA
02/2015 - 08/2004
5PTEN-induced putative kinaseIBA
09/2014 - 08/2007
5Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
02/2006 - 08/2002
4tau Proteins (tau Protein)IBA
11/2015 - 02/2011
4Dopamine Agonists (Dopamine Agonist)IBA
06/2015 - 12/2003
4DNA (Deoxyribonucleic Acid)IBA
03/2015 - 08/2002
4Proteasome Endopeptidase Complex (Proteasome)IBA
04/2014 - 04/2004
4Dopamine (Intropin)FDA LinkGeneric
09/2010 - 11/2006
4cytidylyl-(3'-5')-cytidine (CpC)IBA
12/2005 - 01/2003
3fibrin fragment D (D-dimer)IBA
12/2015 - 10/2012
3rosuvastatin (Crestor)FDA Link
04/2015 - 01/2009
3Glucosylceramidase (Glucocerebrosidase)IBA
04/2015 - 01/2007
3tebufenozide (Mimic)IBA
02/2015 - 01/2011
3Lipoproteins (Lipoprotein)IBA
04/2013 - 01/2009
3pramipexol (pramipexole)FDA LinkGeneric
01/2013 - 01/2011
3Immunoglobulin G (IgG)IBA
01/2013 - 09/2009
3Insulin (Novolin)FDA Link
11/2011 - 01/2003
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2011 - 04/2007
33-Iodobenzylguanidine (Iobenguane)IBA
01/2011 - 10/2005
3Pergolide (Permax)FDA Link
01/2010 - 12/2003
2ApomorphineIBA
11/2015 - 08/2014
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
09/2015 - 09/2010
2Uric Acid (Urate)IBA
03/2015 - 01/2014
2RNA-Binding Proteins (RNA-Binding Protein)IBA
02/2015 - 01/2015
2LithiumIBA
06/2014 - 04/2012
2Glutamic Acid (Glutamate)FDA Link
06/2014 - 07/2009
2Staphylococcal Protein A (A, Protein)IBA
06/2014 - 11/2009
2AdrenomedullinIBA
01/2014 - 11/2009
2Yi-Gan SanIBA
01/2014 - 03/2010
2Amantadine (Aman)FDA LinkGeneric
11/2013 - 01/2008
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
09/2013 - 11/2012
2Peroxidase (Myeloperoxidase)IBA
09/2013 - 11/2012
2LDL CholesterolIBA
04/2013 - 01/2009
2Amyloid (Amyloid Fibrils)IBA
01/2013 - 01/2012
2AutoantibodiesIBA
01/2013 - 04/2006
21- (((alpha- isobutanoyloxyethoxy)carbonyl)aminomethyl)- 1- cyclohexaneacetic acidIBA
01/2013 - 03/2012
2Type 1 Angiotensin ReceptorIBA
07/2012 - 07/2008
2Antipsychotic Agents (Antipsychotics)IBA
01/2012 - 08/2009
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
08/2011 - 08/2011

Therapy/Procedure

5Deep Brain Stimulation
12/2014 - 03/2011
3Activities of Daily Living (ADL)
09/2013 - 03/2009
2Aftercare (After-Treatment)
01/2015 - 10/2012
2Drug Therapy (Chemotherapy)
02/2014 - 05/2013
2Renal Dialysis (Hemodialysis)
01/2013 - 12/2009